Revenue of ToolGen 2015-2023
In 2023, the revenue of ToolGen amounted to around 1.1 billion South Korean won. This represents an increase by almost half compared to previous year's amount. ToolGen is a South Korean biotech company based on CRISPR genome editing technology.